The translational expression of Bax was significantly elevated following OE-miR-4731-5p treatment in NSCLC tissues with reduced protein levels of Bcl-2, Wnt1, and Nuc-β-catenin (Figures 5(j), 5(k), and 5(m)). The gene discussed is BAX; the disease is non-small cell lung carcinoma.